ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Place Based Risk for Early Rejection in Lung Transplant

W. M. Tsuang1, X. Wang2, J. Curtis3

1Respiratory Institute, Cleveland Clinic, Cleveland, OH, 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 3Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH

Meeting: 2022 American Transplant Congress

Abstract number: 1207

Keywords: Lung, Lung transplantation, Rejection, Risk factors

Topic: Clinical Science » Organ Inclusive » 70 - Non-Organ Specific: Disparities to Outcome and Access to Healthcare

Session Information

Session Name: Non-Organ Specific: Disparities to Outcome and Access to Healthcare

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Within 5 years after lung transplant (LT), half of recipients have lost 20% or more of lung function. Despite a consistent link between social and environmental factors with respiratory health, there has not been a place-based investigation of these factors in LT outcomes. Place can be measured via contextual ‘geomarkers’. Similar to how biomarkers (e.g. blood tests) inform clinical decisions, geomarkers are upstream data that precisely risk stratify patients to inform interventions at the patient and policy level. We leveraged U.S. census tracts, which are federally designated small area spatial units that allow for precise patient geolocation and linkage to important non-clinical datasets. Our hypothesis was that census tract-based geomarkers were associated with the risk for biopsy proven acute cellular lung rejection– a serious but mutable risk factor for lung function loss and early mortality.

*Methods: We identified recipients transplanted at our center between January 1, 2016-December 31, 2017 who were permanent residents of Ohio and experienced ≥1 episode of moderate grade biopsy proven acute lung rejection (International Society of Heart and Lung Transplant grade ≥A2). We focused on >3 months after transplant where lung rejection was likely from place-based factors and less likely peri-operative issues. We next identified the latitude and longitude of the residential address in order to geocode the census tract. The tract was then linked to the Center for Disease Control and Prevention’s Social Vulnerability Index (SVI), which scores all U.S. census tracts in four domains: Socioeconomic status, Household composition, Race/ethnicity /language, and Housing/transportation. The SVI ranges from 0 to 1, with higher values indicating greater vulnerability.

*Results: Of 239 transplants during the study period, 45 patients experienced moderate grade rejection. 31 were within 3 months of transplant and 14 were >3 months. Among patients with >3 months rejection, there was a correlation with census tracts predominantly of underrepresented minorities or where English is not the predominant language (SVI: 0.64) when compared to socioeconomic status (SVI: 0.31), household composition (SVI: 0.36) or housing/transportation (SVI: 0.37) (p = 0.007).

*Conclusions: Non-clinical place-based geomarkers may correlate with the risk for lung rejection. Census tracts likely play a key role in identifying and addressing geographic disparities in transplantation. Because acute lung rejection is a mutable risk factor, and a patient’s SVI is readily identifiable, this approach could be quickly translated to individualized clinical care through shortened outpatient follow-up intervals or augmented immunosuppression to improve outcomes for at-risk patients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Tsuang WM, Wang X, Curtis J. Place Based Risk for Early Rejection in Lung Transplant [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/place-based-risk-for-early-rejection-in-lung-transplant/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences